Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Harm reduction and street-based program: looking into Nepal

M Singh1

  • 1Lifesaving and Lifegiving Society, Kathmandu, Nepal.

Substance Use & Misuse
|May 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of maternal labetalol on the newborn infant.

Indian pediatrics·1992
Same author

Attenuation of murine acute lethal graft-versus-host disease by the administration of DL-alpha-difluoromethylornithine.

Clinical immunology and immunopathology·1992
Same author

Prevention of hypoglycemia: a controlled evaluation of sugar fortified milk feeding in small-for-gestational age infants.

Indian pediatrics·1992
Same author

Hypoplastic right ventricle with mild pulmonary stenosis in an adult.

International journal of cardiology·1992
Same author

Enterotoxigenic drug resistant plasmids in animal isolates of Escherichia coli and their zoonotic importance.

The Journal of tropical medicine and hygiene·1992
Same author

Gastric residuals in preterm babies.

Journal of tropical pediatrics·1992
Same journal

Individual and Social Factors Associated with Naswar Consumption Among Adults in Bandar Abbas, Southern Iran.

Substance use & misuse·2026
Same journal

Opioid Message Fatigue in the United States: Prevalence and Associations with Stigma and Policy Support.

Substance use & misuse·2026
Same journal

Why Participants Leave: A Qualitative Study Exploring Dropout from a Medication for Opioid Use Disorder (MOUD) Clinical Trial.

Substance use & misuse·2026
Same journal

Reasons for Discontinuation and Associated Factors in Opioid Agonist Treatment: A Community-Based Study from India.

Substance use & misuse·2026
Same journal

Understanding Daily Cannabis Use among Young Adults in Post-Legalization Québec: Motivations, Consumption Practices, and Control Strategies.

Substance use & misuse·2026
Same journal

Bidirectional Associations Between Alcohol and Tobacco Use in Adults: A Systematic Review of Quantitative Studies on Reciprocal Influences.

Substance use & misuse·2026
See all related articles

The Lifesaving and Lifegiving Society (LALS) in Nepal implemented a harm reduction program for injecting drug users (IDUs), achieving a low HIV prevalence of 1.6% and no new infections in later years.

Area of Science:

  • Public Health
  • Epidemiology
  • HIV/AIDS Prevention

Background:

  • The Lifesaving and Lifegiving Society (LALS) was the first NGO in Nepal to address drug-related harm and HIV/AIDS among injecting drug users (IDUs).
  • The program aimed to reduce the transmission of blood-borne diseases through comprehensive support services.

Purpose of the Study:

  • To evaluate the effectiveness of the LALS harm reduction program in preventing HIV infection among IDUs in Nepal.
  • To assess the prevalence of HIV among IDUs engaged with the program between 1991 and 1994.

Main Methods:

  • The LALS program provided education, counseling, primary health care, bleach, sterile water, condoms, and new needles/syringes to IDUs.
  • HIV prevalence was monitored among IDUs in regular contact with the program from 1991 to 1994.

Related Experiment Videos

Main Results:

  • The prevalence of HIV infection among IDUs in regular contact with the LALS program was 1.6% between 1991 and 1994.
  • No new HIV infections were detected among program participants in 1993 or 1994, indicating program success.

Conclusions:

  • The LALS harm reduction program demonstrated success in controlling HIV transmission among IDUs in Nepal.
  • Despite implementation costs, the program's nonjudgmental approach facilitated engagement, recovery, and public advocacy for drug users.